Bristol-Myers Squibb Co (NYSE:BMY)
| 48.92 Delayed Data As of Nov 28 |  -0.10 / -0.20%Today’s Change | 48.42 Today|||52-Week Range 81.44 | -32.01% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Operating Activities | Net Income / Starting Line | 1.6B | 4.5B | 975.0M | 4.9B | |
| Depreciation | 376.0M | 382.0M | 789.0M | 637.0M | ||
| Total Other Cash Flow | 1.2B | -475.0M | 913.0M | 94.0M | ||
| Funds From Operations | 2.9B | 4.2B | 3.7B | 5.8B | ||
| Funds From/For Other Operating Expenses | 1.0B | 1.4B | -1.6B | -176.0M | ||
| Net Cash Flow - Operating Activities | 1.8B | 2.9B | 5.3B | 5.9B | ||
| Investing | Increase In Investments | -3.1B | -3.1B | -5.4B | -2.3B | |
| Decrease In Investments | 2.8B | 4.8B | 6.4B | 2.4B | ||
| Capital Expenditures | -820.0M | -1.2B | -1.1B | -951.0M | ||
| Fixed Asset Disposal | 708.0M | 1.3B | 722.0M | 1.2B | ||
| Net Assets From Acquisitions | -1.1B | -359.0M | -708.0M | -1.2B | ||
| Net Cash Flow Investing | -1.6B | 1.5B | -66.0M | -874.0M | ||
| Financing | Short Term Borrowings | -449.0M | 125.0M | 727.0M | -543.0M | |
| Long Term Borrowings | 1.3B | 0.00 | 1.5B | 0.00 | ||
| Long Term Debt Reduction | -2.0B | -15.0M | -1.2B | -5.0M | ||
| Net Proceeds Stock Sale | 266.0M | 181.0M | 0.00 | 0.00 | ||
| Common Preferred Redeemed | 0.00 | -231.0M | -2.5B | -320.0M | ||
| Common Dividends | -2.5B | -2.5B | -2.6B | -2.6B | ||
| Cash Dividends Paid - Total | -2.5B | -2.5B | -2.6B | -2.6B | ||
| Other Sources - Financing | -- | 42.0M | 0.00 | 0.00 | ||
| Other Uses - Financing | 2.0M | -- | 22.0M | 54.0M | ||
| Net Cash Flow - Financing | -3.4B | -2.4B | -4.1B | -3.5B | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -95.0M | -33.0M | 52.0M | -41.0M | |
| Net Change In Cash | -3.1B | 1.9B | 1.1B | 1.5B | ||
